TW200604343A - Cellular permissivity factor for viruses, and uses thereof - Google Patents

Cellular permissivity factor for viruses, and uses thereof

Info

Publication number
TW200604343A
TW200604343A TW094112572A TW94112572A TW200604343A TW 200604343 A TW200604343 A TW 200604343A TW 094112572 A TW094112572 A TW 094112572A TW 94112572 A TW94112572 A TW 94112572A TW 200604343 A TW200604343 A TW 200604343A
Authority
TW
Taiwan
Prior art keywords
viruses
cellular
factor
cellular permissivity
permissivity factor
Prior art date
Application number
TW094112572A
Other languages
English (en)
Other versions
TWI354025B (en
Inventor
Jay Gregory Calvert
Shelly Lynn Shields
David Ewell Slade
Welch Siao-Kun Wan
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of TW200604343A publication Critical patent/TW200604343A/zh
Application granted granted Critical
Publication of TWI354025B publication Critical patent/TWI354025B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material
TW94112572A 2004-04-23 2005-04-20 Cellular permissivity factor for viruses, and uses TWI354025B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56521404P 2004-04-23 2004-04-23
US63473604P 2004-12-09 2004-12-09

Publications (2)

Publication Number Publication Date
TW200604343A true TW200604343A (en) 2006-02-01
TWI354025B TWI354025B (en) 2011-12-11

Family

ID=35320736

Family Applications (2)

Application Number Title Priority Date Filing Date
TW94112572A TWI354025B (en) 2004-04-23 2005-04-20 Cellular permissivity factor for viruses, and uses
TW100121989A TWI438278B (zh) 2004-04-23 2005-04-20 針對病毒之細胞允許因子及彼之用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW100121989A TWI438278B (zh) 2004-04-23 2005-04-20 針對病毒之細胞允許因子及彼之用途

Country Status (22)

Country Link
US (4) US7754464B2 (zh)
EP (2) EP1742658B1 (zh)
JP (2) JP5273642B2 (zh)
CN (1) CN102220289B (zh)
AR (3) AR049033A1 (zh)
AU (2) AU2005240002B2 (zh)
BR (1) BRPI0508928B1 (zh)
CA (1) CA2564769C (zh)
CL (1) CL2008002323A1 (zh)
DK (1) DK1742658T3 (zh)
EA (1) EA013071B1 (zh)
ES (2) ES2570665T3 (zh)
HK (1) HK1109065A1 (zh)
IL (1) IL178160A0 (zh)
MA (1) MA28544B1 (zh)
MX (1) MXPA06012216A (zh)
NO (1) NO341211B1 (zh)
NZ (1) NZ550145A (zh)
PL (1) PL1742658T3 (zh)
TW (2) TWI354025B (zh)
UY (1) UY28867A1 (zh)
WO (1) WO2005107796A2 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005107796A2 (en) * 2004-04-23 2005-11-17 Pharmacia & Upjohn Company, Llc Cellular permissivity factor for viruses, and uses thereof
US8202717B2 (en) * 2007-01-12 2012-06-19 The Board Of Trustees Of The University Of Illinois Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus
US8420373B2 (en) * 2007-07-27 2013-04-16 Universiteit Gent Permissive cells and uses thereof
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
JP6386999B2 (ja) 2012-05-17 2018-09-05 ゾエティス・エルエルシー ブタ生殖および呼吸症候群（ｐｒｒｓ）ウイルスに対する離乳前の効果的なワクチン接種
CN103525766B (zh) * 2013-03-24 2015-06-17 西北农林科技大学 一种猪肾细胞系及其应用
GB201313235D0 (en) 2013-07-24 2013-09-04 Univ Edinburgh Antiviral Compositions Methods and Animals
CN104459160A (zh) * 2014-12-30 2015-03-25 洛阳普莱柯万泰生物技术有限公司 试剂盒及其制备方法和使用方法
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
BR112019012158A2 (pt) 2016-12-14 2019-11-12 Zoetis Services Llc vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame
CN108103099B (zh) * 2017-12-18 2022-03-04 中山大学 一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) * 2018-08-13 2022-04-19 江苏省农业科学院 先天性免疫系统重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) * 2020-03-23 2021-05-20 큐벳 주식회사 항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) * 2020-04-22 2023-10-24 The United States Of America, As Represented By The Secretary Of Agriculture Continuous stable cell line for identification of infectious African swine fever virus in clinical samples

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
GB2236186B (en) 1989-08-22 1994-01-05 Finnigan Mat Gmbh Process and device for laser desorption of analyte molecular ions, especially of biomolecules
EP0779362B2 (en) 1989-12-22 2012-06-13 Laboratoires Serono SA DNA constructs for endogenous gene activation and expression modification
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
WO1992020808A1 (en) 1991-05-15 1992-11-26 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en) 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
NZ267842A (en) 1993-05-28 1997-09-22 Baylor College Medicine Apparatus for measuring molecular mass (by mass spectrometry) in which the sample is ionised on the sample holder and desorbed therefrom by laser pulses
DE69522984T2 (de) * 1994-04-11 2002-04-25 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1998035023A1 (en) * 1997-02-07 1998-08-13 Origen, Inc. Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
US6740490B2 (en) * 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
EP1414984B1 (en) 2001-07-24 2018-07-04 Universiteit Gent Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
AU2003243058A1 (en) * 2002-05-27 2003-12-12 Bioceros B.V. Methods for using the cd163 pathway for modulating an immune response
WO2005107796A2 (en) * 2004-04-23 2005-11-17 Pharmacia & Upjohn Company, Llc Cellular permissivity factor for viruses, and uses thereof

Also Published As

Publication number Publication date
EP1742658A2 (en) 2007-01-17
WO2005107796A2 (en) 2005-11-17
EP2520310B1 (en) 2016-03-30
HK1109065A1 (zh) 2008-05-30
JP5600340B2 (ja) 2014-10-01
JP5273642B2 (ja) 2013-08-28
TWI354025B (en) 2011-12-11
MXPA06012216A (es) 2007-01-17
BRPI0508928B1 (pt) 2015-10-06
AU2005240002A1 (en) 2005-11-17
US20120015425A1 (en) 2012-01-19
JP2013078324A (ja) 2013-05-02
TW201134944A (en) 2011-10-16
US9102912B2 (en) 2015-08-11
DK1742658T3 (en) 2015-01-19
CA2564769A1 (en) 2005-11-17
CA2564769C (en) 2013-12-17
WO2005107796A3 (en) 2007-04-12
AU2009202410A1 (en) 2009-07-09
NO20065115L (no) 2006-11-06
US20050271685A1 (en) 2005-12-08
TWI438278B (zh) 2014-05-21
UY28867A1 (es) 2005-11-30
AU2005240002B2 (en) 2009-06-18
JP2007533321A (ja) 2007-11-22
AR084530A2 (es) 2013-05-22
US8058050B2 (en) 2011-11-15
MA28544B1 (fr) 2007-04-03
BRPI0508928A (pt) 2007-08-14
AR049033A1 (es) 2006-06-21
CN102220289A (zh) 2011-10-19
ES2530694T3 (es) 2015-03-04
US20100273238A1 (en) 2010-10-28
EA013071B1 (ru) 2010-02-26
NZ550145A (en) 2009-07-31
EP1742658B1 (en) 2014-12-24
EP1742658A4 (en) 2007-11-28
US7754464B2 (en) 2010-07-13
NO341211B1 (no) 2017-09-11
ES2570665T3 (es) 2016-05-19
US20140141492A1 (en) 2014-05-22
CN102220289B (zh) 2014-05-21
CL2008002323A1 (es) 2008-12-19
EA200601677A1 (ru) 2007-10-26
IL178160A0 (en) 2006-12-31
AR084529A2 (es) 2013-05-22
PL1742658T3 (pl) 2015-05-29
US8486685B2 (en) 2013-07-16
EP2520310A1 (en) 2012-11-07

Similar Documents

Publication Publication Date Title
TW200604343A (en) Cellular permissivity factor for viruses, and uses thereof
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
WO2009024239A3 (en) Permissive cells and uses thereof
MX2009007457A (es) Celulas que no son de mono para el desarrollo del virus del sindrome porcino reproductor y respiratorio (prrs).
MX2009004888A (es) Inhibidores del virus de la hepatitis c.
WO2010025109A8 (en) Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
WO2006078645A3 (en) Heterologous polypeptide expression using low multiplicity of infection of viruses
MX2009004943A (es) Inhibidores del virus de la hepatitis c.
MX2007010220A (es) Peptidos para la deteccion de anticuerpo para el virus del sindrome respiratorio reproductivo porcino.
NO20074885L (no) N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus
SG156666A1 (en) Vaccines against japanese encephalitis virus and west nile virus
MX2009010492A (es) Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped.
BRPI0509077A (pt) método para separar uma olefina de uma corrente gasosa
EP2369001A3 (en) PRRS viruses, infectious clones, mutants thereof, and methods of use
MY150685A (en) Molecules for blocking the infections by flaviviruses
WO2009057239A1 (ja) ろう材、管球、マグネトロンおよびろう付け方法
TW200633948A (en) Composites and methods for the manufacture and use thereof
TR200807139A2 (tr) Suda taşinan aerosol bi̇leşi̇mi̇.
MY149621A (en) Serum-free culture medium for the production of recombinant gonadotropins
WO2004044182A3 (en) Highly permissive cell lines for hepatitis c virus replication
WO2005108560A3 (en) Synthesis and purification of west nile virus virus-like particles
WO2004066923A3 (en) Compositions and methods for improving recovery after general anesthesia
BR0308736A (pt) Células de pulmão de rato cotton para cultura de vìrus
WO2009038858A3 (en) High intensity discharge lamp having composite leg
WO2008068427A3 (fr) Composition terpénique anti-microorganisme